Ssris - Articles - Page 2 | CARLAT PUBLISHING

Management of Psychogenic Polydipsia

July 11, 2022

Psychogenic polydipsia (PP), also known as primary polydipsia and potomania, was first described in the 1930s. It is surprisingly common with a prevalence rate between 3 to 25% in institutionalized patients. In this podcast, we will discuss how to accurately diagnose and manage psychogenic polydipsia in patients.

Uncommon Tips: Which Is Better—Citalopram or Escitalopram?

June 1, 2022

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Citalopram and escitalopram are very similar drugs, but there are reasons to prefer one over the other.

CLINICAL UPDATE

Antidepressants: When Dosage Matters

April 5, 2022

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When it comes to antidepressants, bigger is not better. Here we review the optimal dose ranges for antidepressants, describe how higher doses can worsen symptoms, and show you how to talk to patients about the issue.

Treating Anxiety Disorders in Children: The New AACAP Clinical Practice Guideline

March 24, 2022

Reese Abright, MD

Reese Abright, MD

Director, Division of Child and Adolescent Psychiatry and Fellowship Training Program in Child and Adolescent Psychiatry, Mount Sinai Services - New York City Health + Hospitals/Elmhurst. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai.

Dr. Abright has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There is a new process for sorting and consolidating treatment recommendations: Clinical Practice Guidelines are the new gold standard. We spoke with Dr. A. Reese Abright about the CPG on anxiety disorders to help you understand where the state of the art is for treating the usual disorders that come up in our clinical practice settings.

Comparison of GI Side Effects of Antidepressants

August 3, 2021

Jesus Ligot, MD.

Jesus Ligot, MD. Dr. Ligot has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Modern antidepressants are ranked by their risk of GI side effects, with a few surprises baked in.

SSRIs vs SNRIs in Pediatric Anxiety Disorders: Which Are More Tolerable?

July 14, 2021

John Raiss, MD.

John Raiss, MD. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Which class of medication performs better for treating anxiety or OCD in children and adolescents, SSRI’s or SNRI’s? This study sorts through the comparative efficacy vs. side effects so that you can better decide how to help your patients.

SSRIs and Intracerebral Hemorrhage Risk

May 21, 2021

Paul Barkopoulos, MD.

Paul Barkopoulos, MD. Dr. Barkopoulos has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

SSRIs help relieve post-stroke depression but increase the risk of intracerebral hemorrhage. This study gives us tips to reduce this risk.

Can Antidepressants Prolong Survival in Cancer Patients?

May 21, 2021

Paul Barkopoulos, MD.

Paul Barkopoulos, MD. Dr. Barkopoulos has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Antidepressant adherence is linked with increased survival among cancer patients.

EXPERT Q&A

How to Come Off a Psych Med Part 1: Antipsychotics

February 3, 2021

Swapnil Gupta, MD

Swapnil Gupta, MD
Associate professor at Icahn School of Medicine at Mount Sinai. Co-author of Deprescribing in Psychiatry (Oxford, 2019). Dr. Gupta has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How do you taper off an antipsychotic? Swapnil Gupta gives a practical approach, and discusses dopamine hypersensitivity, a controversial theory that suggests antipsychotic withdrawal can cause dyskinesias, prolactinemia, and rebound psychosis.

How to Select an SSRI

November 12, 2020

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

After digging through 3 decades of research, we can tell you this: There is no such thing as “the best” SSRI. But there are some important differences between them, and this article will show you how to find the right one for your patient.